Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.74 is 96% above its 5-year average of 1.90, around the middle of its 5-year range (0.00–5.61).
As of the fiscal period ended Tuesday, June 30, 2026. 77.41% above its 12-month average of 2.11.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.74.
QUICK RATIO (ACID-TEST)
3.74
QUICK RATIO (ACID-TEST) AVG TTM
2.11
QUICK RATIO (ACID-TEST) AVG 3Y
0.94
QUICK RATIO (ACID-TEST) AVG 5Y
1.90
QUICK RATIO (ACID-TEST) AVG 10Y
2.70
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+77.41%
CURRENT VS 3Y AVG
+297.02%
CURRENT VS 5Y AVG
+96.36%
CURRENT VS 10Y AVG
+38.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
+17.11%
vs the sector median at left
Eloxx Pharmaceuticals, Inc.
Market Cap
$51.13M
Quick Ratio (Acid-Test)
3.74
TTM Avg
2.11
3Y Avg
0.94
5Y Avg
1.90
Market Cap
$51.28M
Quick Ratio (Acid-Test)
5.31
TTM Avg
2.85
3Y Avg
8.26
5Y Avg
15.41
Market Cap
$51.42M
Quick Ratio (Acid-Test)
3.81
TTM Avg
5.31
3Y Avg
3.36
5Y Avg
3.21
Market Cap
$50.78M
Quick Ratio (Acid-Test)
4.04
TTM Avg
3.34
3Y Avg
3.69
5Y Avg
8.08
Market Cap
$51.34M
Quick Ratio (Acid-Test)
1.61
TTM Avg
0.71
3Y Avg
0.60
5Y Avg
0.61
Market Cap
$49.90M
Quick Ratio (Acid-Test)
17.82
TTM Avg
12.77
3Y Avg
7.97
5Y Avg
9.78
Market Cap
$52.47M
Quick Ratio (Acid-Test)
12.87
TTM Avg
3.88
3Y Avg
3.88
5Y Avg
3.88
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $51.13M | 3.74 | 2.11 | 0.94 | 1.90 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.28M | 5.31 | 2.85 | 8.26 | 15.41 |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | 3.81 | 5.31 | 3.36 | 3.21 |
| Clene Inc. (CLNN)vs › | $51.50M | 3.07 | 1.20 | 1.50 | 3.41 |
| INmune Bio, Inc. (INMB)vs › | $50.78M | 4.04 | 3.34 | 3.69 | 8.08 |
| biote Corp. (BTMD)vs › | $52.48M | 0.82 | 0.91 | 2.84 | 2.59 |
| Envoy Medical, Inc. (COCH)vs › | $51.34M | 1.61 | 0.71 | 0.60 | 0.61 |
| Microbot Medical Inc. (MBOT)vs › | $49.90M | 17.82 | 12.77 | 7.97 | 9.78 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.47M | 12.87 | 3.88 | 3.88 | 3.88 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | 3.89 | 3.98 | 6.90 | 10.09 |
Quick Ratio
3.74
Excludes inventory
Current Ratio
3.74
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.74 |
| 2026-03-31 | 0.48 |
| 2025-03-31 | 0.00 |
| 2023-09-30 | 0.24 |
| 2023-06-30 | 0.25 |
| 2023-03-31 | 0.33 |
| 2022-12-31 | 0.87 |
| 2022-09-30 | 1.18 |
| 2022-06-30 | 1.62 |
| 2022-03-31 | 2.20 |
| 2021-12-31 | 4.37 |
| 2021-09-30 | 5.61 |
| 2021-06-30 | 3.85 |
| 2021-03-31 | 1.57 |
| 2020-12-31 | 2.63 |
| 2020-09-30 | 3.23 |
| 2020-06-30 | 3.62 |
| 2020-03-31 | 4.14 |
| 2019-12-31 | 4.89 |
| 2019-09-30 | 5.95 |
| 2019-06-30 | 7.07 |
| 2019-03-31 | 6.58 |
| 2018-12-31 | 6.45 |
| 2018-09-30 | 11.05 |
| 2018-06-30 | 14.69 |
| 2018-03-31 | 3.33 |
| 2017-06-30 | 0.10 |
| 2017-03-31 | 0.26 |
| 2016-12-31 | 0.26 |
| 2016-09-30 | 0.80 |
| 2016-06-30 | 2.66 |
| 2016-03-31 | 4.25 |
| 2015-12-31 | 4.72 |
| 2015-09-30 | 5.41 |
